Back to the overview page

Esther (E) van Wezel

Department
Experimental Immunohematology
E-mail
e.vanwezel@sanquin.nl
Training

Medicine

Research interests
Improvement of risk stratification and treatment allocation for all stages neuroblastoma patients by real time quantitative (RQ)- PCR minimal residual disease (MRD) testing, by using a panel of RQ-PCR targets.
Technology

RQ- PCR based detection of minimal residual disease

Resume
2011-present PhD studen at Dept of Experimental Immunohematology, Sanquin Research, Amsterdam
2008 (Feb-July)Research project at Dept of Molecular Medicine, Institute of Child Health, London, UK
2004-2011Medicine, University of Amsterdam
Publications
Sanquin publications
Last edited on: 23 September 2013
Back to the overview page